Search clinical trials for: epratuzumab
Total 327 results
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
Nantes University HospitalUnknown
-
UCB Biopharma S.P.R.L.Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaboratorsCompletedSystemic Lupus ErythematosusUnited Kingdom
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
UCB PharmaTerminatedLupus Erythematosus, SystemicUnited States
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, Belgium, Netherlands, United Kingdom, Spain, Hungary
-
National Institute of Arthritis and Musculoskeletal...Completed
-
AmgenCompletedNon-Hodgkin's Lymphoma
-
Gilead SciencesCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma
-
Gilead SciencesTerminated
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Gilead SciencesCompleted
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Shanghai Henlius BiotechCompletedHealthy Male VolunteersChina
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Zydus Lifesciences LimitedNot yet recruiting
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Shengjing HospitalNot yet recruiting
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
UCB PharmaCompletedSystemic Lupus ErythematosusJapan
-
UCB PharmaWithdrawnSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Hungary, Czech Republic, Italy, Slovakia
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
BiocadRecruitingBreast CancerRussian Federation
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom, Australia, Belgium, Bulgaria, Czechia, Estonia, Israel, Korea, Republic of, T... and more
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
UCB PharmaCompleted
-
BiocadActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Australia, Belgium, Brazil, Bulgaria, Czechia, Estonia, France, Germany, India, Israel, Italy, Korea, Republic of, Lithuania, Mexico, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Czech Republic, Italy
-
Nantes University HospitalGilead Sciences; Institut Cancerologie de l'OuestWithdrawnLymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
Fudan UniversityCompleted
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
Hospices Civils de LyonNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina